BR0112280A - Nova utilização para deferiprona - Google Patents
Nova utilização para deferipronaInfo
- Publication number
- BR0112280A BR0112280A BR0112280-0A BR0112280A BR0112280A BR 0112280 A BR0112280 A BR 0112280A BR 0112280 A BR0112280 A BR 0112280A BR 0112280 A BR0112280 A BR 0112280A
- Authority
- BR
- Brazil
- Prior art keywords
- deferiprone
- patient
- new use
- cardiac disease
- induced cardiac
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"NOVA UTILIZAçãO PARA DEFERIPRONA". Método de tratamento de doenças cardíacas induzidas por ferro em pacientes com sobrecarga de ferro, tais como em talassemia ou similares, que compreende a administração ao paciente de quantidade terapeuticamente eficaz de deferiprona ou um de seus sais fisiologicamente aceitáveis suficiente para o tratamento de doenças cardíacas induzidas por ferro, normalmente associadas à sobrecarga de ferro.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2313270A CA2313270C (en) | 2000-06-30 | 2000-06-30 | Use of deferiprone in treating and preventing iron-induced cardiac disease |
PCT/CA2001/000956 WO2002002114A1 (en) | 2000-06-30 | 2001-06-28 | A new use for deferiprone |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0112280A true BR0112280A (pt) | 2003-05-13 |
Family
ID=4166629
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0112280-0A BR0112280A (pt) | 2000-06-30 | 2001-06-28 | Nova utilização para deferiprona |
Country Status (16)
Country | Link |
---|---|
US (2) | US7049328B2 (pt) |
EP (1) | EP1294379B1 (pt) |
CN (3) | CN101380322B (pt) |
AT (1) | ATE427107T1 (pt) |
AU (2) | AU2001270402B9 (pt) |
BR (1) | BR0112280A (pt) |
CA (1) | CA2313270C (pt) |
CY (1) | CY1109191T1 (pt) |
DE (1) | DE60138189D1 (pt) |
DK (1) | DK1294379T3 (pt) |
ES (1) | ES2324978T3 (pt) |
HK (2) | HK1043316A1 (pt) |
IL (2) | IL153733A0 (pt) |
PT (1) | PT1294379E (pt) |
WO (1) | WO2002002114A1 (pt) |
ZA (1) | ZA200109322B (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2008010824A (es) * | 2006-02-22 | 2009-06-08 | Arnold Munnich | Uso de deferiprona y metodos para tratar y/o prevenir ataxia de friedreich que resulta de manejo intracelular inadecuado de hierro. |
EP2134688B1 (en) | 2007-03-28 | 2016-10-05 | Apotex Technologies Inc. | Fluorinated derivatives of deferiprone |
MX2010011701A (es) | 2008-04-25 | 2010-12-06 | Apotex Technologies Inc | Formulacion liquida para deferiprona con gusto agradable al paladar. |
WO2011000104A1 (en) | 2009-07-03 | 2011-01-06 | Apotex Technologies Inc. | Fluorinated derivatives of 3-hydroxypyridin-4-ones |
US8603814B2 (en) * | 2009-07-20 | 2013-12-10 | Rutgers The State University Of New Jersey | Method of inhibiting nonsense-mediated mRNA decay |
US9849146B2 (en) | 2009-07-20 | 2017-12-26 | Rutgers, The State University Of New Jersey | Inhibition of nonsense mediated mRNA decay by drugs that prevent hypusination of eukaryotic initiation factor 5A |
JP2014533697A (ja) * | 2011-11-18 | 2014-12-15 | アポテックス テクノロジーズ インコーポレイテッドApotex Technologies Inc. | デフェリプロンを用いた処置方法 |
WO2016029158A2 (en) * | 2014-08-21 | 2016-02-25 | Collaborative Medicinal Development Llc | Compositions and methods for extending lifespan |
WO2018027132A1 (en) * | 2016-08-05 | 2018-02-08 | Abfero Pharmaceuticals, Inc. | Dosing regimens for treating metal-mediated conditions |
CN106983746A (zh) * | 2017-03-23 | 2017-07-28 | 武汉联合药业有限责任公司 | 一种药物组合物及其用途 |
MX2020004107A (es) | 2017-10-25 | 2020-07-24 | Chiesi Farm Spa | Tabletas de deferiprona de liberacion retrasada y metodos de uso de las mismas. |
CN114217071B (zh) * | 2021-12-01 | 2023-11-14 | 柏荣诊断产品(上海)有限公司 | 一种高特异性透散射一体法铁蛋白胶乳比浊检测试剂盒 |
WO2023198640A1 (en) | 2022-04-11 | 2023-10-19 | Chiesi Farmaceutici S.P.A. | Modified release pharmaceutical formulations comprising deferiprone |
CN115429881A (zh) * | 2022-09-02 | 2022-12-06 | 中国医学科学院基础医学研究所 | 铁螯合剂治疗β-连环蛋白活化突变的肿瘤 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2118176B (en) * | 1982-03-24 | 1985-12-04 | Nat Res Dev | Pharmaceutical compositions |
US5922761A (en) * | 1996-09-06 | 1999-07-13 | Medinox, Inc. | Methods for in vivo reduction of iron levels and compositions useful therefor |
-
2000
- 2000-06-30 CA CA2313270A patent/CA2313270C/en not_active Expired - Fee Related
-
2001
- 2001-03-26 CN CN200810128993.5A patent/CN101380322B/zh not_active Expired - Lifetime
- 2001-03-26 CN CN2010102721482A patent/CN101933924A/zh active Pending
- 2001-03-26 CN CN01121242A patent/CN1331971A/zh active Pending
- 2001-06-28 PT PT01949158T patent/PT1294379E/pt unknown
- 2001-06-28 US US10/311,814 patent/US7049328B2/en not_active Expired - Lifetime
- 2001-06-28 BR BR0112280-0A patent/BR0112280A/pt not_active Application Discontinuation
- 2001-06-28 AU AU2001270402A patent/AU2001270402B9/en not_active Expired
- 2001-06-28 DK DK01949158T patent/DK1294379T3/da active
- 2001-06-28 ES ES01949158T patent/ES2324978T3/es not_active Expired - Lifetime
- 2001-06-28 AT AT01949158T patent/ATE427107T1/de active
- 2001-06-28 DE DE60138189T patent/DE60138189D1/de not_active Expired - Lifetime
- 2001-06-28 EP EP01949158A patent/EP1294379B1/en not_active Revoked
- 2001-06-28 WO PCT/CA2001/000956 patent/WO2002002114A1/en active IP Right Grant
- 2001-06-28 AU AU7040201A patent/AU7040201A/xx active Pending
- 2001-06-28 IL IL15373301A patent/IL153733A0/xx unknown
- 2001-11-13 ZA ZA200109322A patent/ZA200109322B/xx unknown
-
2002
- 2002-07-08 HK HK02105057.7A patent/HK1043316A1/zh unknown
- 2002-12-29 IL IL153733A patent/IL153733A/en active IP Right Grant
-
2006
- 2006-01-13 US US11/331,101 patent/US20060122273A1/en not_active Abandoned
-
2009
- 2009-06-29 CY CY20091100679T patent/CY1109191T1/el unknown
- 2009-09-11 HK HK09108345.6A patent/HK1130422A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2313270C (en) | 2011-09-13 |
CA2313270A1 (en) | 2001-12-30 |
CN101380322B (zh) | 2015-06-24 |
CN101933924A (zh) | 2011-01-05 |
US20060122273A1 (en) | 2006-06-08 |
DE60138189D1 (de) | 2009-05-14 |
IL153733A0 (en) | 2003-07-06 |
US7049328B2 (en) | 2006-05-23 |
ZA200109322B (en) | 2002-10-21 |
AU7040201A (en) | 2002-01-14 |
EP1294379B1 (en) | 2009-04-01 |
CN1331971A (zh) | 2002-01-23 |
IL153733A (en) | 2010-04-29 |
PT1294379E (pt) | 2009-05-04 |
CN101380322A (zh) | 2009-03-11 |
ES2324978T3 (es) | 2009-08-21 |
ATE427107T1 (de) | 2009-04-15 |
HK1130422A1 (en) | 2009-12-31 |
WO2002002114A1 (en) | 2002-01-10 |
AU2001270402B9 (en) | 2006-03-02 |
HK1043316A1 (zh) | 2002-09-13 |
DK1294379T3 (da) | 2009-06-02 |
US20030158234A1 (en) | 2003-08-21 |
CY1109191T1 (el) | 2014-07-02 |
AU2001270402B2 (en) | 2006-02-02 |
EP1294379A1 (en) | 2003-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1109191T1 (el) | Μια νεα χρηση της δεφεριπρονης | |
DE60126980D1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
GB0225474D0 (en) | Therapeutic agents | |
HK1091418A1 (en) | Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction | |
CY1109242T1 (el) | Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου | |
TN2011000227A1 (en) | Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy | |
ATE313334T1 (de) | Behandlung von tumoren mit photodynamischer therapie | |
TW200503666A (en) | Treatment of type 1 diabetes with pde5 inhibitors | |
ATE344662T1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
ATE487480T1 (de) | Perhexilin zur behandlung von chronischer herzinsuffizienz | |
SI1596879T1 (sl) | Uporaba spojine kahalalida za pripravo zdravila za zdravljenje luskavice | |
CL2021003303A1 (es) | Tratamiento para sinucleinopatías. | |
EE200200549A (et) | Jagatud doosi teraapia veresooni kahjustava aktiivsusega | |
WO2007117272A3 (en) | Methods for treatment of hemorrhagic shock and related disorders | |
EP1270000A3 (en) | Benzoic acid substituted benzopyrans for the treatment of atherosclerosis | |
BR0316059A (pt) | Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise | |
HK1080768A1 (en) | Use of epothilone derivatives for the treatment ofhyperparathyroidism | |
PT1150680E (pt) | Utilizacao de moxonidima para o tratamento apos enfarte cardiaco | |
RU99122488A (ru) | Способ лечения рака эндометрия |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) DA LPI |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |